Pinnacle Financial Group, Inc.’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.96K Buy
+6,250
New +$2.37K ﹤0.01% 1989

Other funds holding HRTX

Pinnacle Financial Group, Inc.'s HRTX Position: Q3 2026 in Review

Pinnacle Financial Group, Inc. opened a new position in Heron Therapeutics (HRTX) in Q3 2026: 6,250 shares worth $1.96K. The stake represents ﹤0.01% of the portfolio and ranks #1989 among its holdings.

156 funds tracked by Wall St. Rank hold HRTX as of Q3 2026.

  • Pinnacle Financial Group, Inc. held 6,250 shares of Heron Therapeutics worth $1.96K as of Q3 2026.
  • Heron Therapeutics was a new Pinnacle Financial Group, Inc. position in Q3 2026.
  • Heron Therapeutics made up ﹤0.01% of Pinnacle Financial Group, Inc.'s portfolio in Q3 2026, its #1989 holding.
  • 156 funds tracked by Wall St. Rank held Heron Therapeutics as of Q3 2026.

Based on Pinnacle Financial Group, Inc.'s 13F filing for Q3 2026, filed 16 Nov 2026.